| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/23/2009 | WO2009050220A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050218A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050204A1 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 04/23/2009 | WO2009050198A2 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 04/23/2009 | WO2009050183A2 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 04/23/2009 | WO2009049742A2 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 04/23/2009 | WO2009049365A1 A method of prophylaxis and agents for use therein |
| 04/23/2009 | WO2008138658A3 Pharmaceutical compounds comprising abasic oligonucleotides |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105454 Prophylactic/therapeutic agent for cancer |
| 04/23/2009 | US20090105453 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/23/2009 | US20090105317 VEGF Inhibition |
| 04/23/2009 | US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105274 Indolecarboxylic Acid Derivative Having PGD2 Receptor Antagonistic Activity |
| 04/23/2009 | US20090105268 Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors |
| 04/23/2009 | US20090105248 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105236 New pharmaceutically-active compounds for the treatment of respiratory diseases |
| 04/23/2009 | US20090105221 Muscarinic receptor antagonists |
| 04/23/2009 | US20090105218 CRTH2 Receptor Ligands For Therapeutic Use |
| 04/23/2009 | US20090105201 Pulmonary Pharmaceutical Formulations |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104272 Inhaled hypertonic saline delivered by a heated nasal cannula |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104237 Method for increasing tissue oxygenation |
| 04/23/2009 | US20090104213 Vaccine for House Dust Mite Allergen Using Naked DNA |
| 04/23/2009 | DE112004001191T5 Aztreonam L-Lysin und Verfahren für dessen Herstellung Aztreonam L-lysine and method for its preparation |
| 04/23/2009 | DE102007000521A1 Hustenpräparat Cough preparation |
| 04/23/2009 | CA2705414A1 Substituted piperidino-dihydrothienopyrimidines |
| 04/23/2009 | CA2703425A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | CA2703037A1 Organic compounds |
| 04/23/2009 | CA2702942A1 Organic compounds |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2702524A1 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | CA2702518A1 New piperazino-dihydrothienopyrimidine derivatives |
| 04/23/2009 | CA2702473A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2050466A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2050435A1 Cough mixture |
| 04/22/2009 | EP2049533A2 Quinuclidine derivatives as m3 antagonists |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049122A1 Methods and compositions for inhibiting angiogenesis |
| 04/22/2009 | EP2049115A2 Alkyne-substituted pyridone compounds and methods of use |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 04/22/2009 | CN101412709A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 04/22/2009 | CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof |
| 04/22/2009 | CN101411842A Medicament for phlegm and indigestion |
| 04/22/2009 | CN101411839A Chinese medicine oral liquid for treating bacterial pneumonia and preparation method thereof |
| 04/22/2009 | CN101411836A Quality standard of Chinese medicament preparation for treating cough after common cold and inspection method thereof |
| 04/22/2009 | CN101411835A Medicament for treating pneumonectasis and bronchitis and for relieving cough, calming panting, as well as resolving and dispelling phlegm |
| 04/22/2009 | CN101411818A Chinese medicinal granules for treating chronic pharyngitis |
| 04/22/2009 | CN101411817A Oral Chinese medicine for pharyngalgia |
| 04/22/2009 | CN101411816A Medicament for treating chronic pharyngitis |
| 04/22/2009 | CN101411812A Pharmaceutical formulation of Chinese white olive for relieving cough and preparation method thereof |
| 04/22/2009 | CN101411805A Pure natural lozenge for resisting network radiation |
| 04/22/2009 | CN101411804A Mixture for clearing lung-heat and preparation method thereof |
| 04/22/2009 | CN101411792A Medicament for hoarseness and aphonia |
| 04/22/2009 | CN101411790A Oral Chinese medicine for treating pneumonia type influenza |
| 04/22/2009 | CN101411782A Pharmaceutical composition for treating acute pharyngitis and preparation method thereof |
| 04/22/2009 | CN101411752A Granular formulation for treating children's pneumonia |
| 04/22/2009 | CN101411749A Chinese medicinal composition for treating nasal sinusitis and allergic rhinitis |
| 04/22/2009 | CN101411487A Dietotherapy method for treating asthma |
| 04/22/2009 | CN100480440C Method for screening SARS coronaviruses main Protease inhibitors from natural product such as Chinese medicinal materials mixture prepared storeroom |
| 04/22/2009 | CN100479846C Vitamin C and Lonicera and Forsythia capsule |
| 04/22/2009 | CN100479845C Medicinal composition for treating chronic rhinitis and preparation method thereof |
| 04/22/2009 | CN100479833C Extraction method of polygala refined total saponin |
| 04/22/2009 | CN100479805C Chinese caterpillar fungus injection preparation method |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521446 4-({8-[(2,6-Difluorophenyl)amino]-9-cyclopentylpurin-2-yl}amino) trans-cyclohexan-1-ol; mitogen-activated protein (tyrosine) kinase inhibitor; anticarcinogenic, antiinflammatory, analgesic agent, cardiovascular disease, renal disease, autoimmune condition, macular degeneration, pulmonary hypertension |
| 04/21/2009 | US7521438 Allergies,chronic obstructive airway disorders (COPD), e.g. bronchial asthma, chronic obstructive bronchitis, pulmonary emphysema with reversible obstruction, bronchial asthma and other bronchial disorders; side effect reduction |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/16/2009 | WO2009048326A2 Preparation for treatment of a pulmonary disease |
| 04/16/2009 | WO2009046881A1 Use of a peptide combination including c-peptide, as a therapeutic agent |
| 04/16/2009 | WO2009046880A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046879A2 Use of the combination of npy and nociceptin as a therapeutic agent |
| 04/16/2009 | WO2009046878A1 Tnf inhibitory peptide and cgrp as therapeutic agents |
| 04/16/2009 | WO2009046877A2 Use of a histrelin and leuprolide as therapeutic agents |
| 04/16/2009 | WO2009046876A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046875A2 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 04/16/2009 | WO2009046874A1 Therapeutic combination of trh-potentiating peptide and stresscopin |
| 04/16/2009 | WO2009046873A1 Combined use of vasonatrin and gastrin-i as a therapeutic agent |
| 04/16/2009 | WO2009046868A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046867A2 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |